Search Results
Search for other papers by L. R. Altschuler in
Google Scholar
PubMed
Search for other papers by J. A. Ceppi in
Google Scholar
PubMed
Search for other papers by M. N. Ritta in
Google Scholar
PubMed
Search for other papers by R. S. Calandra in
Google Scholar
PubMed
Search for other papers by A. A. Zaninovich in
Google Scholar
PubMed
ABSTRACT
The effects of thyroxine (T4) were studied on the concentration of oestrogen receptors in the anterior pituitary gland and hypothalamus of ovariectomized euthyroid and hypothyroid rats. A group of rats was made hypothyroid by the administration of I. Seven days after ovariectomy, animals were separated into five groups: I, euthyroid controls; II, hypothyroid controls; III, hypothyroid and injected with oestradiol benzoate (10 μg/day for 10 days); IV, hypothyroid and injected with T4 (4 μg/day for 10 days) and V, hypothyroid and injected with both oestradiol and T4 as described above. In group I, oestrogen receptor levels in pituitary cytosol were 44·4 ± 3·4 (s.d.) fmol/mg protein and in the nucleus 47·7 ± 4·0 fmol/mg DNA. In group II the respective values were 12·8 ± 1·7 fmol/mg protein (P <0·01) and 12·7 ± 1·7 fmol/mg DNA (P <0·01 compared with group I). In group III, cytosolic receptor concentrations decreased when compared with those in group II (P <0·05), whereas nuclear receptor concentrations rose significantly (P <0·01). Group IV had both pituitary cytosolic and nuclear receptors increased (P <0·01 compared with group II). In group V there were no changes in cytosolic receptor concentrations but a significant (P <0·01) rise in nuclear receptors as compared with group II. Hypothalamic oestrogen receptors in untreated hypothyroid rats (group II) were unchanged in the cytosol and diminished (P <0·01) in the nucleus in relation to euthyroid controls (group I). Thyroxine, but not oestrogen, was effective in increasing the concentration of cytosolic receptors (P <0·05). Neither hormone caused changes in nuclei. The results show that there is a pronounced decrease in pituitary and hypothalamic (nuclei) oestrogen receptors in untreated hypothyroid rats and that this decrease can be reversed by T4 treatment.
J. Endocr. (1988) 119, 383–387
Search for other papers by CG Korkmaz in
Google Scholar
PubMed
Search for other papers by K Fronsdal in
Google Scholar
PubMed
Search for other papers by Y Zhang in
Google Scholar
PubMed
Search for other papers by PI Lorenzo in
Google Scholar
PubMed
Search for other papers by F Saatcioglu in
Google Scholar
PubMed
Androgens are critical in the development and maintenance of the male reproductive system and important in the progression of prostate cancer. The effects of androgens are mediated by the androgen receptor (AR), which is a ligand-modulated transcription factor that belongs to the nuclear receptor superfamily. We and others have previously shown that CREB-binding protein (CBP) can function as a coactivator for AR. Similar to some other nuclear receptor coactivators and/or the proteins that they interact with, CBP has histone acetyl transferase (HAT) activity that is thought to contribute to transcriptional activation by nuclear receptors. We have therefore assessed whether an increase in the histone acetylation status in the cell can influence AR transcriptional activity, by using the histone deacetylase (HDAC) inhibitors (HDACIs) trichostatin A (TSA), sodium butyrate (Na-But) and depsipeptide (FR901228). We found that inhibition of HDAC activity significantly increased the ability of endogenous AR in LNCaP cells, or ectopically expressed AR in HeLa cells, to activate transcription from AR-dependent reporter constructs. In addition, HDACIs increased the androgen-dependent activation of the prostate-specific antigen (PSA) gene in LNCaP cells, an increase that was not due to an increase in nuclear AR protein levels. Moreover, the viral oncoprotein E1A that inhibits CBP HAT activity fully repressed the ability of HDACIs to stimulate AR-mediated transcription, indicating that CBP is involved in this process. Deletional mutagenesis of AR indicated that whereas the AF-2 domain in the C-terminus is dispensable, the AF-1 domain in the N-terminus is required for augmentation of AR action by HDACIs, an observation which is in concordance with the reduced ability of CBP to activate AR N-terminal deletion mutants. Furthermore, HDACI treatment rescued the deficiency in the transactivation potential of AF-2 mutants. Taken together, our findings suggest that a change in the level of histone acetylation of target genes is an important determinant of AR action, possibly mediated by CBP.
Search for other papers by R.J. Sterling in
Google Scholar
PubMed
Search for other papers by J.M. Gasc in
Google Scholar
PubMed
Search for other papers by P.J. Sharp in
Google Scholar
PubMed
Search for other papers by P. Tuohimaa in
Google Scholar
PubMed
Search for other papers by E.E. Baulieu in
Google Scholar
PubMed
ABSTRACT
Using a double immunohistochemical technique, LH releasing hormone (LHRH) neurones and 110kDa nuclear progesterone receptor were localized in the hypothalamus of the laying hen. Nuclear progesterone receptor was widely distributed throughout the hypothalamus, occurring in the preoptic, septal, anterior and basal areas. The region where progesterone receptor was revealed in nuclei of neurones overlapped that containing LHRH neurones. However, LHRH cell bodies did not contain progesterone nuclear receptor. It is concluded that the positive feedback action of progesterone on LH release is not mediated by a genomic mechanism within the LHRH neurone.
Search for other papers by JM Wentworth in
Google Scholar
PubMed
Search for other papers by TP Burris in
Google Scholar
PubMed
Search for other papers by VK Chatterjee in
Google Scholar
PubMed
A recent prospective clinical study has shown that antiviral therapy with HIV protease inhibitors (PIs) is associated with a syndrome of peripheral fat wasting (lipodystrophy) and disordered glucose and lipid metabolism (Carr et al. 1999). We have studied the effects of indinavir and saquinavir, two HIV protease inhibitors, on cultured primary human preadipocytes and report that these compounds inhibit their differentiation. However, we find that these agents do not inhibit either transcriptional activation or adipocyte P2 gene induction by the PPARgamma/RXR nuclear receptor heterodimer. Together, our findings suggest that impaired adipogenesis is the basis of PI-associated lipodystrophy, but that this occurs via a PPARgamma/RXR-independent mechanism.
Search for other papers by G. B. Kudolo in
Google Scholar
PubMed
Search for other papers by M. G. Elder in
Google Scholar
PubMed
Search for other papers by L. Myatt in
Google Scholar
PubMed
ABSTRACT
Numbers of granulosa cells obtained from follicles of immature rats increased from 1·6 × 105 cells/ovary on day 8 to 7·1 × 106 cells/ovary on day 40 of age, the day of vaginal opening and first pro-oestrus. Very high levels of cytosol oestrogen receptor were found on day 8 (175 000 sites/cell) but by day 19 20 000 sites/cell were found. Nuclear receptor concentrations were highest on day 12(5400 ± 1470 (s.d.) sites/cell) and again on day 21 (5400 ± 2300 sites/cell). After day 21 both cytosol and nuclear oestrogen receptor concentrations fell and remained low until nuclear concentrations rose at day 40. Two consecutive daily injections of FSH/LH (5 i.u.) increased cell number over control in animals killed on day 22, gave no significant alteration in animals killed on day 26 or 28 but decreased numbers in animals aged 32 and 35 days. Only on day 22 was the increase in cell number associated with an increase in nuclear oestrogen receptor concentrations. Indeed on days 32 and 35 increased nuclear receptor concentrations were associated with a decreased cell number.
J. Endocr. (1987) 112, 333–338
Search for other papers by Y. Nishii in
Google Scholar
PubMed
Search for other papers by K. Hashizume in
Google Scholar
PubMed
Search for other papers by K. Ichikawa in
Google Scholar
PubMed
Search for other papers by T. Miyamoto in
Google Scholar
PubMed
Search for other papers by S. Suzuki in
Google Scholar
PubMed
Search for other papers by T. Takeda in
Google Scholar
PubMed
Search for other papers by K. Yamauchi in
Google Scholar
PubMed
Search for other papers by M. Kobayashi in
Google Scholar
PubMed
Search for other papers by T. Yamada in
Google Scholar
PubMed
ABSTRACT
Changes in the amount of cytosolic 3,5,3′-tri-iodo-l-thyronine (T3)-binding protein (CTBP) and its activator during administration of l-thyroxine (T4) to thyroidectomized rats were investigated. Thyroidectomy decreased the amount of CTBP in the kidney, whereas the activator was not significantly modified by thyroidectomy. The activator was increased by administration of T4 to thyroidectomized rats. The amount of CTBP was also increased by administration of T4. The activator increased the maximal binding capacity (MBC) without changes in the affinity constant for T3 binding in CTBP. A T4-induced increase in MBC in cytosol inhibited nuclear T3 binding in vitro by competition of T3 binding between CTBP and the nuclear receptor.
These results suggest that thyroid hormone increases the capacity for cytosolic T3 binding through increasing the amount of CTBP and its activator, and that these increases play a role in regulating the amount of T3 that binds to its nuclear receptor.
Journal of Endocrinology (1989) 123, 99–104
Search for other papers by S. Kyakumoto in
Google Scholar
PubMed
Search for other papers by R. Kurokawa in
Google Scholar
PubMed
Search for other papers by Y. Ohara-Nemoto in
Google Scholar
PubMed
Search for other papers by M. Ota in
Google Scholar
PubMed
ABSTRACT
Cytosol and nuclear androgen receptors in submandibular glands of male and female mice were measured by an exchange assay at 0 °C. The binding of [3H]methyltrienolone to cytosol receptors in females was mostly saturated within a short period of incubation (3 h), whereas the saturation was much slower in males; suggesting that almost all of the cytosol receptors were unoccupied in females and the receptors were partially occupied in males. Nuclear receptors were extracted with pyridoxal 5′-phosphate (5 mmol/l) from nuclear fractions with 93–95% efficiency. The exchange of the bound steroids occurred by 24–48 h at 0 °C, suggesting that most of the nuclear androgen receptor was occupied. The binding was low at higher temperatures, probably due to inactivation of the receptor. Scatchard analysis showed that the apparent dissociation constants of cytosol and nuclear receptors were similar (0·8 and 0·9 nmol/l respectively) in both sexes. On the other hand, the number of androgen-binding sites in the nucleus was much higher in males than in females (1052 fmol/mg DNA and 32 fmol/mg DNA respectively), while the number in the cytosol was higher in females than in males (512 fmol/mg DNA and 368 fmol/mg DNA respectively). These observations show that androgen receptors exist mainly (74%) in the nuclei of males, while they exist mostly (94%) in the cytosol of females.
J. Endocr. (1986) 108, 267–273
Search for other papers by M Lefebvre in
Google Scholar
PubMed
Search for other papers by B Paulweber in
Google Scholar
PubMed
Search for other papers by L Fajas in
Google Scholar
PubMed
Search for other papers by J Woods in
Google Scholar
PubMed
Search for other papers by C McCrary in
Google Scholar
PubMed
Search for other papers by JF Colombel in
Google Scholar
PubMed
Search for other papers by J Najib in
Google Scholar
PubMed
Search for other papers by JC Fruchart in
Google Scholar
PubMed
Search for other papers by C Datz in
Google Scholar
PubMed
Search for other papers by H Vidal in
Google Scholar
PubMed
Search for other papers by P Desreumaux in
Google Scholar
PubMed
Search for other papers by J Auwerx in
Google Scholar
PubMed
Peroxisome proliferator-activated receptor gamma (PPARgamma), a fatty acid-activated nuclear receptor, is implicated in adipocyte differentiation and insulin sensitisation. In view of the association of dietary fat intake and bowel disease, the expression of PPARgamma in rodent and human intestine was studied. Expression of PPARgamma mRNA was examined by Northern blot hybridisation, RNase protection, and/or competitive RT-PCR assays, whereas PPARgamma protein levels were evaluated by immunoblotting and immunohistochemistry. PPARgamma mRNA and protein were abundantly expressed in colon relative to the small intestine both in rodents and in man. Interestingly, expression of PPARgamma was primarily localised in the more differentiated epithelial cells in the colon. The level of expression of PPARgamma in colon was similar to the levels seen in adipose tissue. Expression of PPARgamma increased from proximal to distal segments of the colon in man. In Caco-2 and HT-29 human adenocarcinoma cells, PPARgamma expression increased upon differentiation, consistent with PPARgamma being associated with a differentiated epithelial phenotype. High-level expression of PPARgamma was observed in the colon, but not in the small intestine, suggesting a potential role of this nuclear receptor in the colon.
Search for other papers by KW Lee in
Google Scholar
PubMed
Search for other papers by P Cohen in
Google Scholar
PubMed
Insulin-like growth factor (IGF) binding protein (IGFBP)-3 has been shown to be a growth inhibitory, apoptosis-inducing molecule by virtue of its ability to bind IGFs, in addition to previously demonstrated IGF-independent effects. The recent discovery of the interaction between nuclear IGFBP-3 and 9-cis retinoic acid receptor-alpha (retinoid X receptor alpha RXRalpha), a nuclear receptor, and its involvement in the regulation of transcriptional signaling and apoptosis represents an important paradigm shift in the understanding of IGFBP function. RXRalpha is required for the apoptosis-inducing effects of IGFBP-3. IGFBP-3 and RXR ligands are additive in inducing apoptosis in cancer cells. IGFBP-3 has direct effects on gene transcription, as RXR response element reporter signaling was enhanced and the all-trans retinoic acid receptor response element reporter signaling was inhibited. Accumulating evidence further confirms IGF-independent functions of this multifunction binding protein. Other binding proteins, in addition to other members of the IGF axis, have now been described in the nucleus and are postulated to have effects on transcriptional events. Investigation into these new interactions will expose new protein partners in the interface between the nuclear receptor and growth factor pathways and reveal new targets to be exploited in the treatment of cancer and other diseases.
Search for other papers by E. J. ROY in
Google Scholar
PubMed
Search for other papers by B. S. McEWEN in
Google Scholar
PubMed
Oestrogen receptors were measured by an exchange assay in cell nuclei of the hypothalamus–preoptic area-amygdala (HPA) of ovariectomized-adrenalectomized (OVX-ADX) rats following an intravenous injection of oestradiol or an antioestrogen, CI-628. Receptors were translocated to the nucleus by both compounds. Receptors translocated by the antioestrogen were specific for oestrogens; testosterone, corticosterone and progesterone were not bound by these receptors. Several properties of antioestrogen– and oestradiol–receptor complexes were compared.
The time-course in cell nuclei in vivo showed that receptors were still present in HPA nuclei 24 h after administration of CI-628 but not 24 h after oestradiol. This prolonged increase of nuclear receptors after the antioestrogen treatment was attributed to the continued presence of CI-628 and its metabolites in plasma.
The maximum level of receptors produced in the HPA cell nuclei following CI-628 treatment was lower than the peak level of nuclear receptors following oestradiol. The dissociation rate in vitro of nuclear antioestrogen–receptor complexes formed in vivo was more rapid at 0 °C than that of nuclear oestradiol–receptor complexes. This property may be related to the lower peak level of binding after CI-628 treatment and to the inhibitory actions of antioestrogens.
